Albumin and mortality in upper gastrointestinal bleeding
Downloads
with mortality in UGIB patients is essential for optimizing clinical management and reducing complications. Objective: To assess the predictive value of serum albumin levels for in-hospital mortality in patients with UGIB. Methods: A prospective study was conducted on 91 patients diagnosed with UGIB. Data on demographics, clinical characteristics, and laboratory parameters were collected. Bivariate analyses were performed using Chi-square, Student’s t-test, and Mann-Whitney U test. Significant variables were included in a multivariate logistic regression model to identify independent predictors of mortality. Results: Of the 91 patients, 65.9% were male, with a mean age of 67 ± 15.76 years. Hypoalbuminemia (2.3 g/dL) was significantly associated with mortality in the bivariate analysis (p = 0.01). However, serum albumin did not emerge as an independent predictor in the multivariate analysis (p = 0.257). Independent predictors included the Rockall score (p = 0.011) and length of hospital stay (p = 0.01). Discussion: Although hypoalbuminemia was associated with increased mortality in the bivariate analysis, it was not an independent predictor after adjusting for other clinical variables. The Rockall score and prolonged hospitalization were more robust predictors of mortality, emphasizing the need for multifactorial risk stratification in UGIB patients.
Downloads
1.
Kamboj AK, Hoversten P, Leggett CL. Upper gastrointestinal bleeding: etiologies and management. Mayo Clin Proc. 2019;94(4):697-703. doi:10.1016/j.mayocp.2019.01.022
2.
Oakland K. Changing epidemiology and etiology of upper and lower gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2019;42-43:101610. doi:10.1016/j.bpg.2019.04.003
3.
Pereira Mellado CS. Caracterización epidemiológica y clínica de la hemorragia gastrointestinal superior. Centro Universitario de Oriente (CUNORI), Universidad de San Carlos de Guatemala (USAC). 2017. doi:10.36314/cunori.v3i1.86
4.
Samuel R, Bilal M, Tayyem O, Guturu P. Evaluation and management of non-variceal upper gastrointestinal bleeding. Dis Mon. 2018;64(7):333-343. doi:10.1016/j.disamonth.2018.02.003
5.
Alali AA, Barkun AN. Actualización sobre el tratamiento de la hemorragia gastrointestinal superior no varicosa. Informe Gastroenterol. 2023;11:goad011. doi:10.1093/gastro/goad011
6.
Ungureanu BS. Sangrado gastrointestinal superior. In: Săftoiu A, ed. Guía de Bolsillo para Endoscopia Avanzada en Gastroenterología. Springer; 2023:27. doi:10.1007/978-3-031-42076-4_27
7.
Grossi L, Ciccaglione AF, Marzio L. Esophagitis and its causes: who is "guilty" when acid is found "not guilty"? World J Gastroenterol. 2017;23(17):3011-3016. doi:10.3748/wjg.v23.i17.3011
8.
Ríos León R, Martín Mateos RM, Mateos Muñoz B, Albillos Martínez A. Severe gastrointestinal bleeding due to synchronous herpes simplex virus and cytomegalovirus esophagitis. Gastroenterol Hepatol. 2020;43(8):449-450. doi:10.1016/j.gastrohep.2020.02.014 9.
Wuerth BA, Rockey DC. Changing epidemiology of upper gastrointestinal hemorrhage in the last decade: a nationwide analysis. Dig Dis Sci. 2018;63(5):1286-1293. doi:10.1007/s10620-017-4882-6
10.
Zhang Y, Liu H, Liu X. Salvage treatment for severe upper gastrointestinal bleeding caused by Mallory-Weiss syndrome and myocardial depression after acute myocardial infarction. Heliyon. 2022;8(11):e11638. doi:10.1016/j.heliyon.2022.e11638
11.
Wangrattanapranee P, Khrucharoen U, Jensen D, Wongpongsalee T, Jensen ME. Clinical features and bleeding risk factors. Rev Gastroenterol Mex. 2023. doi:10.1016/j.rgmx.2023.02.057
12.
Wang Y, Bansal P, Li S, Iqbal Z, Cheryala M, Abougergi MS. Dieulafoy's lesion of the upper GI tract: a comprehensive nationwide database analysis. Gastrointest Endosc. 2021;94(1):24-34.e5. doi:10.1016/j.gie.2020.12.015
13.
Jakab SS, Garcia-Tsao G. Evaluation and management of esophageal and gastric varices in patients with cirrhosis. Clin Liver Dis. 2020;24(3):335-350. doi:10.1016/j.cld.2020.04.011
14.
Barkun AN, Bardou M, Kuipers EJ, et al. Management of non-variceal upper gastrointestinal bleeding: guideline recommendations from the International Consensus Group. BMJ Med. 2022;1(1):e000202. doi:10.1136/bmjmed-2022-000202
15.
Leung WK. Artificial intelligence-assisted assessment for Forrest classification of peptic ulcer bleeding: hype or reality? Endoscopy. 2024;56(5):343-344. doi:10.1055/a-2277-2035
16.
Hajiagha Mohammadi AA, Reza Azizi M. Prognostic factors in patients with active non-variceal upper gastrointestinal bleeding. Arab J Gastroenterol. 2019;20(1):23-27. doi:10.1016/j.ajg.2019.01.001
17.
De Simone G, di Masi A, Ascenzi P. Serum albumin: a multifaceted enzyme. Int J Mol Sci. 2021;22(18):10086. doi:10.3390/ijms221810086
18.
González-González JA, Vázquez-Elizondo G, Monreal-Robles R, et al. Hipoalbuminemia en el desenlace clínico de pacientes con sangrado de tubo digestivo alto no variceal. Rev Gastroenterol Mex. 2016;81(4). doi:10.1016/j.rgmx.2016.03.005
19.
Simon TG, Travis AC, Saltzman JR. Initial assessment and resuscitation in nonvariceal upper gastrointestinal bleeding. Gastrointest Endosc Clin N Am. 2015;25(3):429-442. doi:10.1016/j.giec.2015.02.006
20.
Gralnek IM, Dumonceau JM, Kuipers EJ, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2015;47(10):a1-a46. doi:10.1055/s-0034-139317221.
Zhou X, Tripathi D, Song T, et al. Terlipressin for the treatment of acute variceal bleeding: A systematic review and meta-analysis of randomized controlled trials. Medicine. 2018;97(48):e13437. doi:10.1097/MD.0000000000013437
22.
Lau LHS, Sung JJY. Treatment of upper gastrointestinal bleeding in 2020: New techniques and outcomes. Dig Endosc. 2021;33(1):83-94. doi:10.1111/den.13674
23.
Bick BL, Al-Haddad M, Liangpunsakul S, Ghabril MS, DeWitt JM. EUS-guided fine needle injection is superior to direct endoscopic injection of 2-octyl cyanoacrylate for the treatment of gastric variceal bleeding. Surg Endosc. 2019;33(6):1837-1845. doi:10.1007/s00464-018-6462-z
24.
Moledina SM, Komba E. Risk factors for mortality among patients admitted with upper gastrointestinal bleeding at a tertiary hospital: A prospective cohort study. BMC Gastroenterol. 2017;17(1):165. doi:10.1186/s12876-017-0712-8
25.
Gado A, Ebeid B, Abdelmohsen A, Axon A. Clinical outcome of acute upper gastrointestinal hemorrhage among patients admitted to a government hospital in Egypt. Saudi J Gastroenterol. 2016;22(1):9-14. doi:10.4103/1319-3767.170962
26.
Stanley AJ, Laine L, et al. Management of acute upper gastrointestinal bleeding: A national clinical guideline. BMJ. 2017;356:i6432. doi:10.1136/bmj.i6432
27.
Hearnshaw SA, Logan RF, Lowe D, Travis SP, Murphy MF, Palmer KR. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut. 2011;60(10):1327-1335. doi:10.1136/gut.2010.228437
28.
Barkun AN, Almadi M, Kuipers EJ, et al. Management of nonvariceal upper gastrointestinal bleeding: Guideline recommendations from the International Consensus Group. Ann Intern Med. 2019;171(11):805-822. doi:10.7326/M19-1795
29.
He L, Zhang J, Zhang S. Risk factors of in-hospital mortality among patients with upper gastrointestinal bleeding and acute myocardial infarction. Saudi J Gastroenterol. 2018;24(3):177-182. doi:10.4103/sjg.SJG_492_17
30.
Zou D, Qi X, Zhu C, et al. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study. Turk J Gastroenterol. 2016;27(2):180-186. doi:10.5152/tjg.2016.15502
Copyright (c) 2025 Edras Hernandez
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 |
This work is licensed under Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
| Copyright notice |
 |
Authors will retain their copyright and assign to the journal the right of first publication of their work, which will be simultaneously subject to a Creative Commons Attribution-Noncommercial-ShareAlike 4.0 International license (CC BY-NC-SA 4.0) that allows third parties to share the work as long as its author and its first publication in this magazine are indicated. |
|
Authors may adopt other non-exclusive license agreements for the distribution of the version of the published work (eg: deposit it in an institutional repository or publish it in a monographic volume) provided that the initial publication in this journal is indicated. |
|
Authors are allowed and recommended to disseminate their work through the internet (eg, in institutional telematic files or on their website) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The effect of open access). |
| About the Creative Commons license |
|
|
You are free to: |
|
Share — copy and redistribute the material in any medium or format. |
|
Adapt — remix, transform, and build upon the material. |
|
The licensor cannot revoke these freedoms as long as you follow the license terms. |
Under the following terms: |
 |
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. |
 |
NonCommercial — You may not use the material for commercial purposes. |
 |
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. |
| No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. |
